SEPVAZY
LIVE

Serial Number

79449019

Owner

Sandoz AG

Filing Date

Feb 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

SEPVAZY Trademark

Serial Number: 79449019

SEPVAZY is a trademark filed by Sandoz AG on February 20, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Sandoz AG (3 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

February 20, 2026

Registration Date

Not Registered

Goods & Services

Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for prevention and treatment of eye diseases; pharmaceutical preparations for human use for prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for prevention and treatment of kidney diseases; pharmaceutical preparations for human use for prevention and treatment of diabetes; pharmaceutical preparations for human use for prevention and treatment of hypertension; pharmaceutical preparations for human use for prevention and treatment of skin conditions; pharmaceutical preparations for human use in dermatology; pharmaceutical preparations for human use in urology; pharmaceutical preparations for human use in ophthalmology; pharmaceutical preparations for human use for prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for prevention and treatment of allergies; pharmaceutical preparations for human use for prevention and treatment of bone diseases; pharmaceutical preparations for human use for prevention and treatment of respiratory diseases and asthma.

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2026 CNSA
ASSIGNED TO EXAMINER
Jun 3, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
May 20, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 19, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 30, 2026 REPR